Tissue factor in health and disease

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 759-764

  Semeraro, Nicola ^a,b   Colucci, Mario ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; THROMBOPLASTIN;

BLOOD CLOTTING; CONFERENCE PAPER; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRIN DEPOSITION; HEMOSTASIS; HOST CELL; HUMAN; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPSIS; THROMBOEMBOLISM; TUMOR CELL; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

EID: 0030857363     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657625     Document Type: Conference Paper

References (77)

1. Camerer E, Kolsto, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
2. Mueller BM, Reisfeld RA, Edgington TS, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 1992; 89: 11832-6.
3. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994; 94: 1320-7.
4. Nemerson Y. The tissue factor pathway of blood coagulation. In: Hemostasis and thrombosis. Basic principles and clinical practice. Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. J. B. Lippincott Company, Philadelphia, PA 1994; pp 81-93.
5. Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9: 883-9.
6. Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a "prima ballerina". Thromb Haemost 1995; 74: 7-17.
7. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994; 8: 385-90.
8. Drake TA, Morissey JW, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989; 134:1087-97.
9. Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 57: 765-81.
10. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-13.
11. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze, GJJr. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88: 1583-7.
12. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383: 73-5.
13. Bugge TH, Xiao Q, Kombrinck KW, Holmback K, Danton MJS, Colbert MC, Witte DP, Fujikawa K, Davie EN, Degan JL. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996; 93: 6258-61.
14. Bauer KA, Kass BL, ten Cate H, Hawiger J, Rosenberg RD. Factor IX is activated by the tissue factor mechanism. Blood 1990; 76: 731-6.
15. Bauer KA, Kass BL, ten Cate H, Bednarek MA, Hawiger J, Rosenberg RD. Detection of factor X activation in humans. Blood 1989; 74: 2007-15.
16. Francis JL, Carvalho M, Francis DA. The clinical value of tissue factor assays. Blood Coagul Fibrinol 1995; 6 (suppl 1): S37-S44.
17. Levi M, ten Cate H, van der Poll T, van Deventer SJH. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270: 975-9.
18. Semeraro N, Colucci M. Changes in the coagulation-fibrinolysis balance of endothelial cells and mononuclear phagocytes: role in disseminated intravascular coagulation associated with infectious diseases. Int J Clin Lab Res 1992; 21: 214-20.
19. Creasey AA, Chang ACK, Feigen L, Wun T-C, Taylor FB, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993; 91: 2850-60.
20. Semeraro N, Colucci M, Mussoni L, Donau MB. Rat blood leukocytes, unlike rabbit leukocytes, do not generate procoagulant activity on exposure to endotoxin. Br J Exp Path 1981; 62: 638-42.
21. Rothberger H, Dove FB, Lee TK, McGee MP, Kardon B. Procoagulant activity of lymphocyte-macrophage populations in rabbits: selective increases in marrow, blood and spleen cells during Shwartzman reactions. Blood 1983; 61: 712-7.
22. Montemurro P, Lattanzio A, Chetta G, Lupo L, Caputi-Iambrenghi L, Rubino M, Giordano D, Semeraro N. Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after intralipid infusion in rabbits. Blood 1985; 65: 1391-5.
23. Semeraro N, Triggiani R, Montemurro P, Cavallo LG, Colucci M. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits. Thromb Res 1993; 71: 479-86.
24. Mackman N, Sawdey MS, Keeton MR, Loskutoff DJ. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol 1993;143:76-84.
25. Drake TA, Cheng J, Chang A, Taylor FB Jr. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142: 1458-70.
26. Muller-Berghaus G. The role of platelets, leukocytes and complement in the activation of intravascular coagulation by endotoxin. In: Platelets: a multidisciplinary approach. de Gaetano G, Garattini S, eds. Raven Press, New York 1978; pp 303-20.
27. Semeraro N, Montemurro P, Piccoli C, Muolo V, Colucci M, Giuliani G, Fumarola D, Pece Salvatore, Moran AP. Effect of Helicobacter pylori lipopolysaccharide (LPS) and LPS derivatives on the production of tissue factor and plasminogen activator inhibitor type 2 by human blood mononuclear cells. J Infect Dis 1996; 174: 1255-60.
28. Osterud B, Flaegstad T. Increased thromboplastin activity in monocytes of patients with meningococcal infections: related to unfavourable prognosis. Thromb Haemost 1983; 49: 5-7.
29. Almdahl SM, Brox JH, Osterud B. Mononuclear phagocyte thromboplastin and endotoxin in patients with secondary peritonitis. Scand J Gastroenterol 1987; 22: 914-18.
30. Semeraro N, Montemurro P, Chetta G, Altomare DF, Giordano D, Colucci M. Increased procoagulant activity of peripheral blood monocytes in human and experimental obstructive jaundice. Gastroenterology 1989; 96: 892-8.
31. Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in adult respiratory distress syndrome. J Clin Invest 1989; 84:695-705.
32. Haj MA, Neilly IJ, Robbie LA, Adey GD, Bennett B. Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leucopenia. Br J Haematol 1995; 90: 541-7.
33. Clozel M, Kuhn H, Baumgartner HR. Procoagulant activity of endotoxin-treated human endothelial cells exposed to native human flowing blood. Blood 1989; 73: 729-33.
34. Barstad RM, Hamers MJAG, Kierulf P, Westvik AB, Sakariassen KS. Procoagulant human monocytes mediate tissue factor/factor VIIa-dependent platelet-thrombus formation when exposed to flowing nonanticoagulated human blood. Arterioscler Thromb Vasc Biol 1995; 15: 11-6.
35. Kato K, Ali Elsayed Y, Namoto M, Nakagawa K, Sueishi K. Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits. Thromb Res 1996; 82: 335-47.
36. Semeraro N, Montemurro P, Giordano D, Pasquetto N, Curci E, Triggiani R, Colucci M. Increased macrophage procoagulant activity but normal endothelial thrombomodulin in rabbits fed an atherogenic diet. Haemostasis 1990; 20-54-61.
37. Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253-9.
38. Speidel CM, Eisenberg PR, Ruf W, Edgington TS, Abendschein DR. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation 1995; 92: 3323-30.
39. Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N, Scognamiglio A, Trimarco B, Iaccarino G, Condorelli M, Chiariello M, Ambrosio G. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nature Med 1996; 2: 35-40.
40. Tipping PG, Malliaros J, Holdsworth SR. Procoagulant activity expression by macrophages from atheromatous plaques. Atherosclerosis 1989; 79: 237-43.
41. Annex BH, Denning SM, Channon KM, Sketch, Jr MH, Stack RS, Morissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-22.
42. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94: 1226-32.
43. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 1996; 75: 451-61.
44. Moreno PR, Bernardi VH, Lopez-Cuéllar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT. Macrophages, smooth muscle cells, and tissue factor in unstable angina - Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 1996; 94: 3090-7.
45. Neri Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, Dabizzi P, Poggesi L, Modesti PA, Trotta F, Rostagno C, Boddi M, Gensini GF. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86: 790-7.
46. Jude B, Agaou B, McFadden EP, Susen S, Bauters C, Lepelley P, Vanhaesbroucke C, Devos P, Cosson A, Asseman P. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 1994; 90: 1662-8.
47. Leatham EW, Bath PMW, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73: 10-3.
48. Thomas D. Venous thrombogenesis. Br Med Bull 1994; 50: 803-12.
49. Scagnol I, Fumagalli G, Colucci M, Semeraro N. Induction of venous thrombosis by monocyte procoagulant activity in rabbits. Thromb Haemost 1991; 65: 1086.
50. Bernat A, Sainte-Marie M, Roque C, Ingelaere V, Maffrand JP, Herbert JM. Low doses of endotoxin potentiate venous thrombosis in the rabbit. Haemostasis 1994; 24: 209-18.
51. Miller CL, Graziano C, Lim RC, Chin M. Generation of tissue factor by patient monocytes: correlation to thromboembolic complications. Thromb Haemost 1981; 42: 489-95.
52. Blakowski, SA, Zackarski LR, Beck JR. Postoperative elevation of human peripheral blood monocyte tissue factor coagulant activity. J Lab Clin Med 1986; 108: 117-20.
53. Ollivier V, Sheibani A, Chollet-Martin S, Vie P, Benacerraf R, Duparc J, de Prost D. Monocyte procoagulant activity and membrane-associated D Dimer after knee replacement surgery. Thromb Res 1989; 55: 179-85.
54. Dvorak HF. Abnormalities of hemostasis in malignant disease. In: Hemostasis and thrombosis. Basic principles and clinical practice. Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. J. B. Lippincott Company, Philadelphia, PA 1994; pp 1238-54.
55. Donati MB, Semeraro N. Cancer cell procoagulants and their pharmacological modulation. Haemostasis 1984; 14: 422-9.
56. Rickles FR, Edwards RL. Leukocytes and tumor cells in thrombosis. In: Hemostasis and thrombosis. Basic principles and clinical practice. Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. J. B. Lippincott Company, Philadelphia, PA 1994; pp 1164-79.
57. Rambaldi A, Alessio G, Casali B, Passerini CG, Donati MB, Mantovani A, Semeraro N. Induction of monocyte-macrophage procoagulant activity by transformed cell lines. J Immunol 1986; 136: 3848-55.
58. Tanaka M, Yamanishi H. The expression of tissue factor antigen and activity on the surface of leukemic cells. Leuk Res 1993; 17: 103-11.
59. Conese M, Montemurro P, Fumarulo R, Giordano D, Riccardi S, Colucci M, Semeraro N. Inhibitory effect of retinoids on the generation of procoagulant activity by blood mononuclear cells. Thromb Haemost 1991; 66: 662-5.
60. De Stefano V, Teofili L, Sica S, Mastrangelo S, Di Mario A, Rutella S, Salutari P, Rumi C, d'Onofrio G, Leone G. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood 1995; 86: 3535-41.
61. Falanga A, Iacoviello L, Evangelista V, Belotti D, Consonni R, D'Orazio A, Robba L, Donati MB, Barbui T. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood 1995; 86: 1072-81.
62. Callander NS, Varki N, Rao LVM. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992; 70: 1194-201.
63. Costantini V, Zackarski LR. Fibrin and cancer. Thromb Haemost 1993; 69: 406-14.
64. Hamada K, Kuratsu J, Saitoh, Takeshima H, Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 1996; 77: 1877-83.
65. Chen Z, Sager R. Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas. Mol Med 1995; 1: 153-60.
66. Semeraro N. Different expression of procoagulant activity in macrophages associated with experimental and human tumors. Haemostasis 1988; 18: 47-54.
67. Semeraro N, Montemurro P, Conese M, Giordano D, Stella M, Restaino A, Cagnazzo G, Colucci M: Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int J Cancer 45, 251-254, 1990
68. Mantovani A, Semeraro N. Tumor-associated macrophages and their modulatory role in tumor progression. In: Tumor matrix biology. Adany R, ed. CRC Press, Boca Raton, F1 1995; pp 173-87.
69. Ruco LP, Pittiglio M, Dejana E, Baroni CD. Vascular activation in the histopathogenesis of Hodgkin's disease: potential role of endothelial tissue factor in intravascular thrombosis and necrosis. J Pathol 1993; 171: 131-6.
70. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast cancer. Nature Med 1996; 2: 209-15.
71. Vrana JA, Stang MT, Grande JP, Getz MJ. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: Paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res 1996; 56: 5063-70.
72. Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RCN. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 1995; 82: 1101-4.
73. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995; 92: 8205-9.
74. Morgan D, Edwards RL, Rickles FR. Monocyte procoagulant activity as a peripheral marker of clottin activation in cancer patients. Haemostasis 1988; 18. 55-65.
75. Semeraro N, Montemurro P, Giordano P, Santoro N, De Mattia D, Colucci M. Increased mononuclear cell tissue factor and type 2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma. Thromb Haemost 1994; 72: 54-7.
76. Montemurro P, Conese M, Altomare DF, Memeo V, Colucci M, Semeraro N. Blood and tissue fibrinolytic profiles in patients with colorectal carcinoma. Int J Clin Lab Res 1995; 25: 195-200.
77. Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson RCN. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346: 1004-5.